Cargando…
Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma
BACKGROUND: The purpose of this study is to predict overall survival (OS) and lung cancer-specific survival (LCSS) in patients with stage IIIA-N2 unresectable lung squamous cell cancer (LUSC), lung adenocarcinoma (LUAD), and large cell neuroendocrine cancer (LCNEC) by constructing nomograms and to c...
Autores principales: | Yang, Ying, Shen, Cheng, Shao, Jingjing, Wang, Yilang, Wang, Gaoren, Shen, Aiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282874/ https://www.ncbi.nlm.nih.gov/pubmed/35847910 http://dx.doi.org/10.3389/fonc.2022.825598 |
Ejemplares similares
-
Risk Stratification for Lung Cancer Patients
por: Jain, Anchal, et al.
Publicado: (2022) -
Role of cuproptosis-related gene in lung adenocarcinoma
por: Liu, Yuan, et al.
Publicado: (2022) -
Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection
por: Lowczak, Anna, et al.
Publicado: (2020) -
Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis
por: de Bessa, Camila Martins, et al.
Publicado: (2022) -
A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis
por: Sun, Shuang, et al.
Publicado: (2021)